For provoked VTE, what is the recommended duration of DOAC therapy?

For provoked VTE, what is the recommended duration of DOAC therapy?

• A. 1 month
• B. 6 months
• C. 12 months
• D. 3 months

Answer: (D)

Provoked VTE should be treated with a finite, time-limited course of anticoagulation because the triggering factor is temporary and the risk of recurrence drops once it resolves. Three months of DOAC therapy is the standard duration in this setting, balancing effectiveness with bleeding risk. Extending therapy beyond three months is typically not needed unless there are persistent risk factors or the VTE is unprovoked. Shorter than three months is usually insufficient to treat the clot, while longer durations are more appropriate for unprovoked VTE or cancer-associated cases. So, three months of DOAC therapy best fits provoked VTE.

Provoked VTE should be treated with a finite, time-limited course of anticoagulation because the triggering factor is temporary and the risk of recurrence drops once it resolves. Three months of DOAC therapy is the standard duration in this setting, balancing effectiveness with bleeding risk. Extending therapy beyond three months is typically not needed unless there are persistent risk factors or the VTE is unprovoked. Shorter than three months is usually insufficient to treat the clot, while longer durations are more appropriate for unprovoked VTE or cancer-associated cases. So, three months of DOAC therapy best fits provoked VTE.